A labeled molecule can be followed through a biological system, but the label may remain after the original molecule has broken apart. Chemical separation is therefore essential to interpretation. Primary study
What was reported
The investigators developed uniformly tritium-labeled peptide methods using extraction, chromatography, and scintillation counting. They studied Selank and Pro-Gly-Pro degradation in plasma, with additional brain-tissue investigation after intranasal administration. Major Selank breakdown products included shorter peptides such as TKPRP, TKP, RP, and GP. Primary report
Our appraisal: distinguish location, identity, and quantity
A radioactivity signal answers where labeled material was detected. It does not automatically identify whether that material was intact Selank, a peptide fragment, or another labeled product. Chromatographic separation makes the question more specific by distinguishing components before quantification.
Recovery is another consideration. Extraction efficiency can differ among intact peptide and fragments, so the measured mixture depends partly on analytical performance. A sound interpretation requires attention to recovery controls, peak assignment, and how concentrations were calculated.
Detection in a tissue also differs from evidence of a pharmacological effect there. Material may be present without reaching the relevant cell compartment, receptor, or effective concentration. Demonstrating distribution and demonstrating biological action are complementary, not equivalent, tasks.
The same caution applies to half-life claims. A numerical half-life requires a defined analyte, time course, and model. It cannot be inferred merely from identifying degradation products or from the duration of a behavioral response in another experiment.
This work is useful for understanding how peptide metabolism can be investigated. It does not make all Selank fragments interchangeable with the parent compound, establish human brain exposure, or provide a validated human administration schedule.
Frequently asked questions
Was radioactive labeling used?
Yes, tritium labeling.
Were breakdown products separated?
The method included chromatography.
Were shorter Selank fragments identified?
Yes.
Is total radioactivity necessarily intact Selank?
No.
Does tissue detection alone demonstrate a therapeutic effect?
No.
Can a human half-life be inferred from fragment names?
No.
Are fragments automatically equivalent to the parent peptide?
No.